ID

30861

Descrizione

Study of Natalizumab in Relapsed/Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00675428

collegamento

https://clinicaltrials.gov/show/NCT00675428

Keywords

versioni (1)
  1. 27/06/18 27/06/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

27 giugno 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Multiple Myeloma NCT00675428

Inglese

Eligibility Multiple Myeloma NCT00675428

1 moduli  
Criteria
Descrizione

Criteria

relapsed or refractory multiple myeloma that was treated with or was considered inappropriate for treatment with bortezomib and an imid® drug (including an analogue).
Descrizione

Recurrent multiple myeloma | Refractory multiple myeloma | Bortezomib | Immunomodulators | Bortezomib Analogue | Immunomodulator Analogue | Patients Inappropriate Bortezomib | Patients Inappropriate Immunomodulators

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1370446
UMLS CUI [2]
C0278620
UMLS CUI [3]
C1176309
UMLS CUI [4]
C1527392
UMLS CUI [5,1]
C1176309
UMLS CUI [5,2]
C0243071
UMLS CUI [6,1]
C1527392
UMLS CUI [6,2]
C0243071
UMLS CUI [7,1]
C0030705
UMLS CUI [7,2]
C1548788
UMLS CUI [7,3]
C1176309
UMLS CUI [8,1]
C0030705
UMLS CUI [8,2]
C1548788
UMLS CUI [8,3]
C1527392
eastern cooperative oncology group (ecog) performance status ≤2.
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
corrected calcium <10.6 mg/dl.
Descrizione

Corrected serum calcium measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0455288
key exclusion criteria:
Descrizione

Exclusion Criteria Main

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
candidates for stem cell transplantation willing to undergo transplantation. (subjects who are candidates for stem cell transplantation, but are not willing to undergo transplant will be eligible for the study.)
Descrizione

Patients Appropriate Stem cell transplant | Transplantation Receive Willing

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C1504389
UMLS CUI [2,1]
C0040732
UMLS CUI [2,2]
C1514756
UMLS CUI [2,3]
C0600109
autologous stem cell transplantation <3 months post-transplant.
Descrizione

Transplantation of autologous hematopoietic stem cell | Time Period Post Transplantation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1831743
UMLS CUI [2,1]
C1948053
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C0040732
prior allogeneic stem cell transplantation.
Descrizione

Allogeneic Stem Cell Transplantation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2242529
nonsecretory myeloma.
Descrizione

Non-secretory myeloma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0456845
plasma cell leukemia (>2000/µl circulating plasma cells by standard cell counting differential), hyperleukocytosis (white blood cells >100,000/µl), clinical evidence of hyperviscosity syndrome, or polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome (poems), or primary systemic amyloidosis.
Descrizione

Leukemia, Plasma Cell | Circulating Plasma Cell Differential cell count method Standard | Hyperleukocytosis | White Blood Cell Count procedure | Hyperviscosity syndrome | POEMS Syndrome | Primary Systemic Amyloidosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023484
UMLS CUI [2,1]
C3811668
UMLS CUI [2,2]
C2591490
UMLS CUI [2,3]
C1442989
UMLS CUI [3]
C4324336
UMLS CUI [4]
C0023508
UMLS CUI [5]
C0221030
UMLS CUI [6]
C0085404
UMLS CUI [7]
C0281479
subjects who cannot undergo a brain magnetic resonance imaging (mri) study.
Descrizione

MRI Receive Unable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
clinically significant (as determined by the investigator) 12 lead electrocardiogram (ecg) abnormalities, including qtc prolongation (>450 ms in males, >470 ms in females).
Descrizione

12 lead ECG Abnormality | Prolonged QTc interval | Gender

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C1704258
UMLS CUI [2]
C1560305
UMLS CUI [3]
C0079399
note: other protocol defined inclusion/exclusion criteria may apply.
Descrizione

Eligibility Criteria Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Ritorna all'inizio della pagina

Similar models

Eligibility Multiple Myeloma NCT00675428

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Recurrent multiple myeloma | Refractory multiple myeloma | Bortezomib | Immunomodulators | Bortezomib Analogue | Immunomodulator Analogue | Patients Inappropriate Bortezomib | Patients Inappropriate Immunomodulators
Item
relapsed or refractory multiple myeloma that was treated with or was considered inappropriate for treatment with bortezomib and an imid® drug (including an analogue).
boolean
C1370446 (UMLS CUI [1])
C0278620 (UMLS CUI [2])
C1176309 (UMLS CUI [3])
C1527392 (UMLS CUI [4])
C1176309 (UMLS CUI [5,1])
C0243071 (UMLS CUI [5,2])
C1527392 (UMLS CUI [6,1])
C0243071 (UMLS CUI [6,2])
C0030705 (UMLS CUI [7,1])
C1548788 (UMLS CUI [7,2])
C1176309 (UMLS CUI [7,3])
C0030705 (UMLS CUI [8,1])
C1548788 (UMLS CUI [8,2])
C1527392 (UMLS CUI [8,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status ≤2.
boolean
C1520224 (UMLS CUI [1])
Corrected serum calcium measurement
Item
corrected calcium <10.6 mg/dl.
boolean
C0455288 (UMLS CUI [1])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Patients Appropriate Stem cell transplant | Transplantation Receive Willing
Item
candidates for stem cell transplantation willing to undergo transplantation. (subjects who are candidates for stem cell transplantation, but are not willing to undergo transplant will be eligible for the study.)
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C1504389 (UMLS CUI [1,3])
C0040732 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Transplantation of autologous hematopoietic stem cell | Time Period Post Transplantation
Item
autologous stem cell transplantation <3 months post-transplant.
boolean
C1831743 (UMLS CUI [1])
C1948053 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0040732 (UMLS CUI [2,3])
Allogeneic Stem Cell Transplantation
Item
prior allogeneic stem cell transplantation.
boolean
C2242529 (UMLS CUI [1])
Non-secretory myeloma
Item
nonsecretory myeloma.
boolean
C0456845 (UMLS CUI [1])
Leukemia, Plasma Cell | Circulating Plasma Cell Differential cell count method Standard | Hyperleukocytosis | White Blood Cell Count procedure | Hyperviscosity syndrome | POEMS Syndrome | Primary Systemic Amyloidosis
Item
plasma cell leukemia (>2000/µl circulating plasma cells by standard cell counting differential), hyperleukocytosis (white blood cells >100,000/µl), clinical evidence of hyperviscosity syndrome, or polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome (poems), or primary systemic amyloidosis.
boolean
C0023484 (UMLS CUI [1])
C3811668 (UMLS CUI [2,1])
C2591490 (UMLS CUI [2,2])
C1442989 (UMLS CUI [2,3])
C4324336 (UMLS CUI [3])
C0023508 (UMLS CUI [4])
C0221030 (UMLS CUI [5])
C0085404 (UMLS CUI [6])
C0281479 (UMLS CUI [7])
MRI Receive Unable
Item
subjects who cannot undergo a brain magnetic resonance imaging (mri) study.
boolean
C0024485 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
12 lead ECG Abnormality | Prolonged QTc interval | Gender
Item
clinically significant (as determined by the investigator) 12 lead electrocardiogram (ecg) abnormalities, including qtc prolongation (>450 ms in males, >470 ms in females).
boolean
C0430456 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C1560305 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Eligibility Criteria Study Protocol
Item
note: other protocol defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial